Biosketch / Results /

Andrew Talal

Adjunct Associate Professor, Department of Medicine

Contact Info

212/745-4495
Andrew.Talal@nyumc.org


Determinants of treatment completion and efficacy in drug users assessed by meta-analysis
Dimova, R B; Zeremski, M; Jacobson, I M; Hagan, H; Des, Jarlais D C; Talal, A. Determinants of treatment completion and efficacy in drug users assessed by meta-analysis [Meeting Abstract]. Hepatology. 2012 October;56:657A-657A (207622)

Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis
Dimova, Rositsa B; Zeremski, Marija; Jacobson, Ira M; Hagan, Holly; Des Jarlais, Don C; Talal, Andrew H. Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis. Clinical infectious diseases. 2012 Dec 7;56(6):806-816 (249362)

Absolute and relative contraindications to pegylatedinterferon (PEG-IFN) or ribavirin (RBV) in the US general patient population with chronic Hepatitis C (HCV): Results from US Database of Over 45,000 Patients
Talal, A; LaFleur, J; Hoop, R S; Pandya, P K; Martin, P; Jacobson, I M; Han, J; Korner, E. Absolute and relative contraindications to pegylatedinterferon (PEG-IFN) or ribavirin (RBV) in the US general patient population with chronic Hepatitis C (HCV): Results from US Database of Over 45,000 Patients [Meeting Abstract]. Hepatology. 2012 October;56:650A-650A (206142)

Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, Eric; Talal, Andrew H; Sherman, Kenneth E; Schiff, Eugene R; Saab, Sammy. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver international. 2011 Mar 16;31(8):1090-1101 (143762)

Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
Charles, Edgar D; Brunetti, Claudia; Marukian, Svetlana; Ritola, Kimberly D; Talal, Andrew H; Marks, Kristen; Jacobson, Ira M; Rice, Charles M; Dustin, Lynn B. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood. 2011 Mar 18;117(20):5425-5437 (143763)